⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NRXP News
NRX Pharmaceuticals, Inc. Common Stock
Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight
prnewswire.com
ABBV
ALTO
NRXP
VNDA
HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD
globenewswire.com
NRXP
New to The Street Broadcasts Tonight on Bloomberg Television at 6:30 PM EST - Shows 736, 737 and 738 Air Across the U.S., Latin America and MENA
accessnewswire.com
YYGH
SAGT
MDCX
VTIX
NRXP
SNYR
NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer
globenewswire.com
NRXP
New to The Street and Wall Street New York Magazine Launch Weekly Executive Publication with Integrated NewsOut Video Press Distribution
accessnewswire.com
VRTX
NRXP
ONCO
LPCN
RDZN
BIVI
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting
globenewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
prnewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
accessnewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
globenewswire.com
NRXP
Bronstein, Gewirtz & Grossman LLC Urges NowRx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
NRXP